{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:26:50Z","timestamp":1792985210490,"version":"4.5.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/pr.2017.243","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T16:01:16Z","timestamp":1506441676000},"page":"372-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Promoting neuroregeneration after perinatal arterial ischemic stroke: neurotrophic factors and mesenchymal stem cells"],"prefix":"10.1038","volume":"83","author":[{"given":"Nienke","family":"Wagenaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline G M","family":"de Theije","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris","family":"Groenendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon J N L","family":"Benders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora H A","family":"Nijboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"BFpr2017243_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1474-4422(14)70227-3","volume":"14","author":"A Kirton","year":"2015","unstructured":"Kirton A, DeVeber G . Paediatric stroke: pressing issues and promising directions. Lancet Neurol 2015;14:92\u2013102.","journal-title":"Lancet Neurol"},{"key":"BFpr2017243_CR2","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1161\/STROKEAHA.109.564633","volume":"40","author":"N Agrawal","year":"2009","unstructured":"Agrawal N, Johnston SC, Wu YW, Sidney S, Fullerton HJ . Imaging data reveal a higher pediatric stroke incidence than prior us estimates. Stroke 2009;40:3415\u20133421.","journal-title":"Stroke"},{"key":"BFpr2017243_CR3","doi-asserted-by":"publisher","first-page":"e1402","DOI":"10.1542\/peds.2011-1148","volume":"128","author":"A Kirton","year":"2011","unstructured":"Kirton A, Armstrong-Wells J, Chang T et al. Symptomatic neonatal arterial ischemic stroke: the International Pediatric Stroke Study. Pediatrics 2011;128:e1402\u2013e1410.","journal-title":"Pediatrics"},{"key":"BFpr2017243_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/apa.12555","volume":"103","author":"N Van der Aa","year":"2014","unstructured":"Van der Aa N, Benders M, Groenendaal F, de Vries L . Neonatal stroke: a review of the current evidence on epidemiology, pathogenesis, diagnostics and therapeutic options. Acta Paediatr 2014;103:356\u2013364.","journal-title":"Acta Paediatr"},{"key":"BFpr2017243_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/jcbfm.2014.41","volume":"34","author":"D Fern\u00e1ndez-L\u00f3pez","year":"2014","unstructured":"Fern\u00e1ndez-L\u00f3pez D, Natarajan N, Ashwal S, Vexler ZS . Mechanisms of perinatal arterial ischemic stroke. J Cereb Blood Flow Metab 2014;34:921\u2013932.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFpr2017243_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jpeds.2016.02.064","volume":"173","author":"M Martinez-Biarge","year":"2016","unstructured":"Martinez-Biarge M, Cheong JLY, Diez-Sebastian J, Mercuri E, Dubowitz LMS, Cowan FM . Risk factors for neonatal arterial ischemic stroke: the importance of the intrapartum period. J Pediatr 2016;173:62\u20138.e1.","journal-title":"J Pediatr"},{"key":"BFpr2017243_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1001\/archpediatrics.2011.1772","volume":"166","author":"Ma Tagin","year":"2012","unstructured":"Tagin M a, Woolcott CG, Vincer MJ, Whyte RK, Stinson DA . Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis. Arch Pediatr Adolesc Med 2012;166:558\u2013566.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"BFpr2017243_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0378-3782(98)00033-4","volume":"53","author":"AJ Gunn","year":"1998","unstructured":"Gunn AJ, Gunn TR . The \u201cpharmacology\u201d of neuronal rescue with cerebral hypothermia. Early Hum Dev 1998;53:19\u201335.","journal-title":"Early Hum Dev"},{"key":"BFpr2017243_CR9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2174\/157015910793358150","volume":"8","author":"X Fan","year":"2010","unstructured":"Fan X, Kavelaars A, Heijnen CJ, Groenendaal F, van Bel F . Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury. Curr Neuropharmacol 2010;8:324\u2013334.","journal-title":"Curr Neuropharmacol"},{"key":"BFpr2017243_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/jcbfm.2013.3","volume":"33","author":"V Donega","year":"2013","unstructured":"Donega V, van Velthoven CTJ, Nijboer CH, Kavelaars A, Heijnen CJ . The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment. J Cereb Blood Flow Metab 2013;33:625\u2013634.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFpr2017243_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bbr.2008.08.003","volume":"197","author":"SD Kadam","year":"2009","unstructured":"Kadam SD, Mulholland JD, Smith DR, Johnston MV, Comi AM . Chronic brain injury and behavioral impairments in a mouse model of term neonatal strokes. Behav Brain Res 2009;197:77\u201383.","journal-title":"Behav Brain Res"},{"key":"BFpr2017243_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/brainsci5020165","volume":"5","author":"A Larpthaveesarp","year":"2015","unstructured":"Larpthaveesarp A, Ferriero D, Gonzalez F . Growth factors for the treatment of ischemic brain injury (growth factor treatment). Brain Sci 2015;5:165\u2013177.","journal-title":"Brain Sci"},{"key":"BFpr2017243_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ana.410090206","volume":"9","author":"JE Rice","year":"1981","unstructured":"Rice JE, Vannucci RC, Brierley JB . The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981;9:131\u2013141.","journal-title":"Ann Neurol"},{"key":"BFpr2017243_CR14","first-page":"89","volume":"40","author":"RC Vannucci","year":"1993","unstructured":"Vannucci RC . Experimental models of perinatal hypoxic-ischemic brain damage. APMIS Suppl 1993;40:89\u201395.","journal-title":"APMIS Suppl"},{"key":"BFpr2017243_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.expneurol.2013.04.015","volume":"247","author":"M Tsuji","year":"2013","unstructured":"Tsuji M, Ohshima M, Taguchi A, Kasahara Y, Ikeda T, Matsuyama T . A novel reproducible model of neonatal stroke in mice: comparison with a hypoxia-ischemia model. Exp Neurol 2013;247:218\u2013225.","journal-title":"Exp Neurol"},{"key":"BFpr2017243_CR16","doi-asserted-by":"publisher","first-page":"F65","DOI":"10.1136\/fn.75.1.F65","volume":"75","author":"P Williamson","year":"1996","unstructured":"Williamson P, Griffiths G, Norfolk D, Levene M . Blood transfusions and human recombinant erythropoietin in premature newborn infants. Arch Dis Child Fetal Neonatal Ed 1996;75:F65\u2013F68.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"BFpr2017243_CR17","doi-asserted-by":"crossref","unstructured":"Ohlsson A, Aher SM . Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database Syst Rev 2006: CD004863.","DOI":"10.1002\/14651858.CD004863.pub2"},{"key":"BFpr2017243_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.clp.2015.04.004","volume":"42","author":"SE Juul","year":"2015","unstructured":"Juul SE, Pet GC . Erythropoietin and neonatal neuroprotection. Clin Perinatol 2015;42:469\u2013481.","journal-title":"Clin Perinatol"},{"key":"BFpr2017243_CR19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1242\/dev.129.2.505","volume":"129","author":"X Yu","year":"2002","unstructured":"Yu X, Shacka JJ, Eells JB et al. Erythropoietin receptor signalling is required for normal brain development. Development 2002;129:505\u2013516.","journal-title":"Development"},{"key":"BFpr2017243_CR20","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1166\/jnn.2014.8728","volume":"14","author":"J Lu","year":"2014","unstructured":"Lu J, Jiang L, Zhu H, Zhang L, Wang T . Hypoxia-inducible factor-1\u03b1 and erythropoietin expression in the hippocampus of neonatal rats following hypoxia-ischemia. J Nanosci Nanotechnol 2014;14:5614\u20135619.","journal-title":"J Nanosci Nanotechnol"},{"key":"BFpr2017243_CR21","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/00004647-199906000-00007","volume":"19","author":"M Bernaudin","year":"1999","unstructured":"Bernaudin M, Marti HH, Roussel S et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999;19:643\u2013651.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFpr2017243_CR22","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/sj.bjp.0705161","volume":"138","author":"ZZ Chong","year":"2003","unstructured":"Chong ZZ, Kang JQ, Maiese K . Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br J Pharmacol 2003;138:1107\u20131118.","journal-title":"Br J Pharmacol"},{"key":"BFpr2017243_CR23","doi-asserted-by":"publisher","first-page":"9733","DOI":"10.1523\/JNEUROSCI.21-24-09733.2001","volume":"21","author":"T Shingo","year":"2001","unstructured":"Shingo T, Sorokan ST, Shimazaki T, Weiss S . Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 2001;21:9733\u20139743.","journal-title":"J Neurosci"},{"key":"BFpr2017243_CR24","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1161\/01.STR.0000132196.49028.a4","volume":"35","author":"L Wang","year":"2004","unstructured":"Wang L, Zhang Z, Wang Y, Zhang R, Chopp M . Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004;35:1732\u20131737.","journal-title":"Stroke"},{"key":"BFpr2017243_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.nbd.2010.01.015","volume":"38","author":"D Osredkar","year":"2010","unstructured":"Osredkar D, Sall JW, Bickler PE, Ferriero DM . Erythropoietin promotes hippocampal neurogenesis in in vivo models of neonatal stroke. Neurobiol Dis 2010;38:259\u2013265.","journal-title":"Neurobiol Dis"},{"key":"BFpr2017243_CR26","doi-asserted-by":"publisher","first-page":"110R","DOI":"10.1203\/01.PDR.0000159571.50758.39","volume":"57","author":"A Sola","year":"2005","unstructured":"Sola A, Wen T-C, Hamrick SEG, Ferriero DM . Potential for protection and repair following injury to the developing brain: a role for erythropoietin? Pediatr Res 2005;57:110R\u2013117R.","journal-title":"Pediatr Res"},{"key":"BFpr2017243_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000105473","volume":"29","author":"FF Gonzalez","year":"2007","unstructured":"Gonzalez FF, McQuillen P, Mu D et al. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci 2007;29:321\u2013330.","journal-title":"Dev Neurosci"},{"key":"BFpr2017243_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1159\/000232558","volume":"31","author":"FF Gonzalez","year":"2009","unstructured":"Gonzalez FF, Abel R, Almli CR, Mu D, Wendland M, Ferriero DM . Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Dev Neurosci 2009;31:403\u2013411.","journal-title":"Dev Neurosci"},{"key":"BFpr2017243_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1203\/01.PDR.0000163616.89767.69","volume":"58","author":"YS Chang","year":"2005","unstructured":"Chang YS, Mu D, Wendland M et al. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 2005;58:106\u2013111.","journal-title":"Pediatr Res"},{"key":"BFpr2017243_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainresrev.2008.04.007","volume":"59","author":"MA Van der Kooij","year":"2008","unstructured":"Van der Kooij MA, Groenendaal F, Kavelaars A, Heijnen CJ, van Bel F . Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia\/ischemia. Brain Res Rev 2008;59:22\u201333.","journal-title":"Brain Res Rev"},{"key":"BFpr2017243_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.nbd.2016.04.006","volume":"93","author":"A Larpthaveesarp","year":"2016","unstructured":"Larpthaveesarp A, Georgevits M, Ferriero DM, Gonzalez FF . Delayed erythropoietin therapy improves histological and behavioral outcomes after transient neonatal stroke. Neurobiol Dis 2016;93:57\u201363.","journal-title":"Neurobiol Dis"},{"key":"BFpr2017243_CR32","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/STROKEAHA.111.000104","volume":"44","author":"FF Gonzalez","year":"2013","unstructured":"Gonzalez FF, Larpthaveesarp A, McQuillen P et al. Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke. Stroke 2013;44:753\u2013758.","journal-title":"Stroke"},{"key":"BFpr2017243_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/08977190410001723308","volume":"22","author":"DK Binder","year":"2004","unstructured":"Binder DK, Scharfman HE . Brain-derived neurotrophic factor. Growth Factors 2004;22:123\u2013131.","journal-title":"Growth Factors"},{"key":"BFpr2017243_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2008.01.033","volume":"132","author":"C Zhao","year":"2008","unstructured":"Zhao C, Deng W, Gage FH . Mechanisms and functional implications of adult neurogenesis. Cell 2008;132:645\u2013660.","journal-title":"Cell"},{"key":"BFpr2017243_CR35","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/00004647-199705000-00003","volume":"17","author":"WR Sch\u00e4bitz","year":"1997","unstructured":"Sch\u00e4bitz WR, Schwab S, Spranger M, Hacke W . Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1997;17:500\u2013506.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFpr2017243_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000454949","volume":"39","author":"J Diaz","year":"2017","unstructured":"Diaz J, Abiola S, Kim N et al. Therapeutic hypothermia provides variable protection against behavioral deficits after neonatal hypoxia-ischemia: a potential role for brain-derived neurotrophic factor. Dev Neurosci 2017;39:257\u2013272.","journal-title":"Dev Neurosci"},{"key":"BFpr2017243_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/00207454.2012.744755","volume":"123","author":"Y Wang","year":"2013","unstructured":"Wang Y, Cao M, Liu A et al. Changes of inflammatory cytokines and neurotrophins emphasized their roles in hypoxic-ischemic brain damage. Int J Neurosci 2013;123:191\u2013195.","journal-title":"Int J Neurosci"},{"key":"BFpr2017243_CR38","doi-asserted-by":"crossref","unstructured":"Huang W, Meng F, Cao J, Liu X, Zhang J, Li M . Neuroprotective role of exogenous brain-derived neurotrophic factor in hypoxia-hypoglycemia-induced hippocampal neuron injury via regulating Trkb\/MiR134 signaling. J Mol Neurosci 2017: 134.","DOI":"10.1007\/s12031-017-0907-z"},{"key":"BFpr2017243_CR39","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.neulet.2006.08.059","volume":"407","author":"R Deumens","year":"2006","unstructured":"Deumens R, Koopmans GC, Jaken RJP et al. Stimulation of neurite outgrowth on neonatal cerebral astrocytes is enhanced in the presence of BDNF. Neurosci Lett 2006;407:268\u2013273.","journal-title":"Neurosci Lett"},{"key":"BFpr2017243_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2006.05.010","volume":"202","author":"KJ Dixon","year":"2006","unstructured":"Dixon KJ, Sherrard RM . Brain-derived neurotrophic factor induces post-lesion transcommissural growth of olivary axons that develop normal climbing fibers on mature Purkinje cells. Exp Neurol 2006;202:44\u201356.","journal-title":"Exp Neurol"},{"key":"BFpr2017243_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neuroscience.2013.06.050","volume":"250","author":"S Morcuende","year":"2013","unstructured":"Morcuende S, Mu\u00f1oz-Hern\u00e1ndez R, Ben\u00edtez-Temi\u00f1o B, Pastor AM, de la Cruz RR . Neuroprotective effects of NGF, BDNF, NT-3 and GDNF on axotomized extraocular motoneurons in neonatal rats. Neuroscience 2013;250:31\u201348.","journal-title":"Neuroscience"},{"key":"BFpr2017243_CR42","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/cercor\/bhh127","volume":"15","author":"I Husson","year":"2005","unstructured":"Husson I, Rangon CM, Leli\u00e8vre V et al. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex 2005;15:250\u2013261.","journal-title":"Cereb Cortex"},{"key":"BFpr2017243_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/NEN.0b013e3181ccc9a9","volume":"69","author":"L Sentilhes","year":"2010","unstructured":"Sentilhes L, Michel C, Lecourtois M et al. Vascular endothelial growth factor and its high-affinity receptor (VEGFR-2) are highly expressed in the human forebrain and cerebellum during development. J Neuropathol Exp Neurol 2010;69:111\u2013128.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFpr2017243_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2009.03.091","volume":"461","author":"L Zhang","year":"2009","unstructured":"Zhang L, Qu Y, Yang C et al. Signaling pathway involved in hypoxia-inducible factor-1alpha regulation in hypoxic-ischemic cortical neurons in vitro. Neurosci Lett 2009;461:1\u20136.","journal-title":"Neurosci Lett"},{"key":"BFpr2017243_CR45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/B978-0-12-386986-9.00012-0","volume":"102","author":"JV Lafuente","year":"2012","unstructured":"Lafuente JV, Ortuzar N, Bengoetxea H, Bulnes S, Argando\u00f1a EG . Vascular endothelial growth factor and other angioglioneurins. Key molecules in brain development and restoration. Int Rev Neurobiol 2012;102:317\u2013346.","journal-title":"Int Rev Neurobiol"},{"key":"BFpr2017243_CR46","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nature04481","volume":"438","author":"DA Greenberg","year":"2005","unstructured":"Greenberg DA, Jin K . From angiogenesis to neuropathology. Nature 2005;438:954\u2013959.","journal-title":"Nature"},{"key":"BFpr2017243_CR47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbr.2012.01.026","volume":"230","author":"XR Zheng","year":"2012","unstructured":"Zheng XR, Zhang SS, Yin F et al. Neuroprotection of VEGF-expression neural stem cells in neonatal cerebral palsy rats. Behav Brain Res 2012;230:108\u2013115.","journal-title":"Behav Brain Res"},{"key":"BFpr2017243_CR48","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.nbd.2003.08.020","volume":"14","author":"D Mu","year":"2003","unstructured":"Mu D, Jiang X, Sheldon RA et al. Regulation of hypoxia-inducible factor 1alpha and induction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiol Dis 2003;14:524\u2013534.","journal-title":"Neurobiol Dis"},{"key":"BFpr2017243_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.braindev.2009.01.004","volume":"32","author":"J Sun","year":"2010","unstructured":"Sun J, Zhou W, Sha B, Yang Y . Ischemia induced neural stem cell proliferation and differentiation in neonatal rat involved vascular endothelial growth factor and transforming growth factor-beta pathways. Brain Dev 2010;32:191\u2013200.","journal-title":"Brain Dev"},{"key":"BFpr2017243_CR50","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1161\/STROKEAHA.109.564229","volume":"41","author":"J Shimotake","year":"2010","unstructured":"Shimotake J, Derugin N, Wendland M, Vexler ZS, Ferriero DM . Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke. Stroke 2010;41:343\u2013349.","journal-title":"Stroke"},{"key":"BFpr2017243_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12975-012-0221-6","volume":"4","author":"M Dzietko","year":"2013","unstructured":"Dzietko M, Derugin N, Wendland MF, Vexler ZS, Ferriero DM . Delayed VEGF treatment enhances angiogenesis and recovery after neonatal focal rodent stroke. Transl Stroke Res 2013;4:189\u2013200.","journal-title":"Transl Stroke Res"},{"key":"BFpr2017243_CR52","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1172\/JCI9369","volume":"106","author":"ZG Zhang","year":"2000","unstructured":"Zhang ZG, Zhang L, Jiang Q et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000;106:829\u2013838.","journal-title":"J Clin Invest"},{"key":"BFpr2017243_CR53","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.brainresbull.2009.11.012","volume":"81","author":"XR Zheng","year":"2010","unstructured":"Zheng XR, Zhang SS, Yang YJ et al. Adenoviral vector-mediated transduction of VEGF improves neural functional recovery after hypoxia-ischemic brain damage in neonatal rats. Brain Res Bull 2010;81:372\u2013377.","journal-title":"Brain Res Bull"},{"key":"BFpr2017243_CR54","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1203\/PDR.0b013e318180ebe6","volume":"64","author":"Y Feng","year":"2008","unstructured":"Feng Y, Rhodes PG, Bhatt AJ . Neuroprotective effects of vascular endothelial growth factor following hypoxic ischemic brain injury in neonatal rats. Pediatr Res 2008;64:370\u2013374.","journal-title":"Pediatr Res"},{"key":"BFpr2017243_CR55","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1126\/science.8493557","volume":"260","author":"L Lin","year":"1993","unstructured":"Lin L, Doherty D, Lile J, Bektesh S, Collins F . GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993;260:1130\u20131132.","journal-title":"Science"},{"key":"BFpr2017243_CR56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0006-8993(97)00347-8","volume":"762","author":"H Junger","year":"1997","unstructured":"Junger H, Varon S . Neurotrophin-4 (NT-4) and glial cell line-derived neurotrophic factor (GDNF) promote the survival of corticospinal motor neurons of neonatal rats in vitro. Brain Res 1997;762:56\u201360.","journal-title":"Brain Res"},{"key":"BFpr2017243_CR57","doi-asserted-by":"publisher","first-page":"9771","DOI":"10.1073\/pnas.92.21.9771","volume":"92","author":"L Li","year":"1995","unstructured":"Li L, Wu W, Lin LF, Lei M, Oppenheim RW, Houenou LJ . Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc Natl Acad Sci USA 1995;92:9771\u20139775.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2017243_CR58","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/373339a0","volume":"373","author":"KD Beck","year":"1995","unstructured":"Beck KD, Valverde J, Alexi T et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 1995;373:339\u2013341.","journal-title":"Nature"},{"key":"BFpr2017243_CR59","first-page":"905","volume":"18","author":"S-J Li","year":"2014","unstructured":"Li S-J, Liu W, Wang J-L et al. The role of TNF-\u03b1, IL-6, IL-10, and GDNF in neuronal apoptosis in neonatal rat with hypoxic-ischemic encephalopathy. Eur Rev Med Pharmacol Sci 2014;18:905\u2013909.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"BFpr2017243_CR60","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/(SICI)1097-4695(199701)32:1<22::AID-NEU3>3.0.CO;2-G","volume":"32","author":"CR Matheson","year":"1997","unstructured":"Matheson CR, Carnahan J, Urich JL, Bocangel D, Zhang TJ, Yan Q . Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophic factor for sensory neurons: comparison with the effects of the neurotrophins. J Neurobiol 1997;32:22\u201332.","journal-title":"J Neurobiol"},{"key":"BFpr2017243_CR61","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0006-8993(01)02364-2","volume":"903","author":"WR Zhang","year":"2001","unstructured":"Zhang WR, Hayashi T, Iwai M et al. Time dependent amelioration against ischemic brain damage by glial cell line-derived neurotrophic factor after transient middle cerebral artery occlusion in rat. Brain Res 2001;903:253\u2013256.","journal-title":"Brain Res"},{"key":"BFpr2017243_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2009.05.100","volume":"1284","author":"B Chen","year":"2009","unstructured":"Chen B, Gao X-Q, Yang C-X et al. Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Res 2009;1284:1\u201311.","journal-title":"Brain Res"},{"key":"BFpr2017243_CR63","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1172\/JCI200420935","volume":"113","author":"M Dezawa","year":"2004","unstructured":"Dezawa M, Kanno H, Hoshino M et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 2004;113:1701\u20131710.","journal-title":"J Clin Invest"},{"key":"BFpr2017243_CR64","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V . Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008;8:726\u2013736.","journal-title":"Nat Rev Immunol"},{"key":"BFpr2017243_CR65","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315\u2013317.","journal-title":"Cytotherapy"},{"key":"BFpr2017243_CR66","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/pr.2012.71","volume":"72","author":"ES Kim","year":"2012","unstructured":"Kim ES, Ahn SY, Im GH et al. Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats. Pediatr Res 2012;72:277\u2013284.","journal-title":"Pediatr Res"},{"key":"BFpr2017243_CR67","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","volume":"88","author":"L Danielyan","year":"2009","unstructured":"Danielyan L, Sch\u00e4fer R, von Ameln-Mayerhofer A et al. Intranasal delivery of cells to the brain. Eur J Cell Biol 2009;88:315\u2013324.","journal-title":"Eur J Cell Biol"},{"key":"BFpr2017243_CR68","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3727\/096368912X657251","volume":"22","author":"N Wei","year":"2013","unstructured":"Wei N, Yu SP, Gu X et al. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell Transplant 2013;22:977\u2013991.","journal-title":"Cell Transplant"},{"key":"BFpr2017243_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.expneurol.2014.06.009","volume":"261","author":"V Donega","year":"2014","unstructured":"Donega V, Nijboer CH, van Tilborg G, Dijkhuizen RM, Kavelaars A, Heijnen CJ . Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury. Exp Neurol 2014;261:53\u201364.","journal-title":"Exp Neurol"},{"key":"BFpr2017243_CR70","doi-asserted-by":"crossref","unstructured":"Wei ZZ, Gu X, Ferdinand A et al. Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats. Cell Transplant 2015: 1\u201340.","DOI":"10.3727\/096368915X686887"},{"key":"BFpr2017243_CR71","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/jnr.23954","volume":"95","author":"CT Van Velthoven","year":"2017","unstructured":"Van Velthoven CT, Dzietko M, Wendland MF et al. Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats. J Neurosci Res 2017;95:1225\u20131236.","journal-title":"J Neurosci Res"},{"key":"BFpr2017243_CR72","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1161\/STROKEAHA.111.000326","volume":"44","author":"CTJ Van Velthoven","year":"2013","unstructured":"Van Velthoven CTJ, Sheldon RA, Kavelaars A et al. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 2013;44:1426\u20131432.","journal-title":"Stroke"},{"key":"BFpr2017243_CR73","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.bbi.2011.03.021","volume":"25","author":"CTJ Van Velthoven","year":"2011","unstructured":"Van Velthoven CTJ, Kavelaars A, van Bel F, Heijnen CJ . Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav Immun 2011;25:1342\u20131348.","journal-title":"Brain Behav Immun"},{"key":"BFpr2017243_CR74","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3171\/spi.2007.6.5.412","volume":"6","author":"N Kamei","year":"2007","unstructured":"Kamei N, Tanaka N, Oishi Y et al. Bone marrow stromal cells promoting corticospinal axon growth through the release of humoral factors in organotypic cocultures in neonatal rats. J Neurosurg Spine 2007;6:412\u2013419.","journal-title":"J Neurosurg Spine"},{"key":"BFpr2017243_CR75","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1203\/00006450-201011001-00834","volume":"68","author":"CTJ Van Velthoven","year":"2010","unstructured":"Van Velthoven CTJ, Kavelaars A, van Bel F, Heijnen CJ . Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatr Res 2010;68:419\u2013422.","journal-title":"Pediatr Res"},{"key":"BFpr2017243_CR76","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3109\/02688699008992734","volume":"4","author":"AJ Bower","year":"1990","unstructured":"Bower AJ . Plasticity in the adult and neonatal central nervous system. Br J Neurosurg 1990;4:253\u2013264.","journal-title":"Br J Neurosurg"},{"key":"BFpr2017243_CR77","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000125479","volume":"3","author":"GE Schneider","year":"1970","unstructured":"Schneider GE . Mechanisms of functional recovery following lesions of visual cortex or superior colliculus in neonate and adult hamsters. Brain Behav Evol 1970;3:295\u2013323.","journal-title":"Brain Behav Evol"},{"key":"BFpr2017243_CR78","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/ana.22518","volume":"70","author":"L Titomanlio","year":"2011","unstructured":"Titomanlio L, Kavelaars A, Dalous J et al. Stem cell therapy for neonatal brain injury: perspectives and challenges. Ann Neurol 2011;70:698\u2013712.","journal-title":"Ann Neurol"},{"key":"BFpr2017243_CR79","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0197-4580(03)00083-6","volume":"25","author":"L Bondolfi","year":"2004","unstructured":"Bondolfi L, Ermini F, Long JM, Ingram DK, Jucker M . Impact of age and caloric restriction on neurogenesis in the dentate gyrus of C57BL\/6 mice. Neurobiol Aging 2004;25:333\u2013340.","journal-title":"Neurobiol Aging"},{"key":"BFpr2017243_CR80","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1523\/JNEUROSCI.16-06-02027.1996","volume":"16","author":"HG Kuhn","year":"1996","unstructured":"Kuhn HG, Dickinson-Anson H, Gage FH . Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 1996;16:2027\u20132033.","journal-title":"J Neurosci"},{"key":"BFpr2017243_CR81","doi-asserted-by":"publisher","first-page":"17169","DOI":"10.1073\/pnas.0708228104","volume":"104","author":"B Leuner","year":"2007","unstructured":"Leuner B, Kozorovitskiy Y, Gross CG, Gould E . Diminished adult neurogenesis in the marmoset brain precedes old age. Proc Natl Acad Sci USA 2007;104:17169\u201317173.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2017243_CR82","first-page":"491","volume-title":"Handbook of the Neuroscience of Aging","author":"A Comi","year":"2009","unstructured":"Comi A, Johnston M Stroke: neonate vs. adult In:. Handbook of the Neuroscience of Aging. Elsevier, 2009 pp 491\u2013494."},{"key":"BFpr2017243_CR83","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1227\/NEU.0b013e31820c048e","volume":"68","author":"Y Takeshima","year":"2011","unstructured":"Takeshima Y, Nakamura M, Miyake H et al. Neuroprotection with intraventricular brain-derived neurotrophic factor in rat venous occlusion model. Neurosurgery 2011;68:1334\u20131341.","journal-title":"Neurosurgery"},{"key":"BFpr2017243_CR84","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1161\/01.STR.31.9.2212","volume":"31","author":"WR Sch\u00e4bitz","year":"2000","unstructured":"Sch\u00e4bitz WR, Sommer C, Zoder W, Kiessling M, Schwaninger M, Schwab S . Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke 2000;31:2212\u20132217.","journal-title":"Stroke"},{"key":"BFpr2017243_CR85","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3892\/mmr.2012.1069","volume":"6","author":"A Zhang","year":"2012","unstructured":"Zhang A, Liang L, Niu H, Xu P, Hao Y . Protective effects of VEGF treatment on focal cerebral ischemia in rats. Mol Med Rep 2012;6:1315\u20131318.","journal-title":"Mol Med Rep"},{"key":"BFpr2017243_CR86","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1161\/01.STR.29.7.1417","volume":"29","author":"H Kitagawa","year":"1998","unstructured":"Kitagawa H, Hayashi T, Mitsumoto Y, Koga N, Itoyama Y, Abe K . Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. Stroke 1998;29:1417\u20131422.","journal-title":"Stroke"},{"key":"BFpr2017243_CR87","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1161\/STROKEAHA.109.555789","volume":"40","author":"J Minnerup","year":"2009","unstructured":"Minnerup J, Heidrich J, Rogalewski A, Sch\u00e4bitz WR, Wellmann J . The efficacy of erythropoietin and its analogues in animal stroke models: a meta-analysis. Stroke 2009;40:3113\u20133120.","journal-title":"Stroke"},{"key":"BFpr2017243_CR88","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/j.1582-4934.2009.00987.x","volume":"15","author":"S Lanfranconi","year":"2011","unstructured":"Lanfranconi S, Locatelli F, Corti S et al. Growth factors in ischemic stroke. J Cell Mol Med 2011;15:1645\u20131687.","journal-title":"J Cell Mol Med"},{"key":"BFpr2017243_CR89","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.brainres.2015.12.058","volume":"1634","author":"V Neubauer","year":"2016","unstructured":"Neubauer V, Wegleiter K, Posod A et al. Delayed application of the haematopoietic growth factors G-CSF\/SCF and FL reduces neonatal excitotoxic brain injury. Brain Res 2016;1634:94\u2013103.","journal-title":"Brain Res"},{"key":"BFpr2017243_CR90","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.expneurol.2014.10.004","volume":"263","author":"L Li","year":"2015","unstructured":"Li L, Klebe D, Doycheva D et al. G-CSF ameliorates neuronal apoptosis through GSK-3\u03b2 inhibition in neonatal hypoxia-ischemia in rats. Exp Neurol 2015;263:141\u2013149.","journal-title":"Exp Neurol"},{"key":"BFpr2017243_CR91","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3349\/ymj.2008.49.5.836","volume":"49","author":"BR Kim","year":"2008","unstructured":"Kim BR, Shim JW, Sung DK et al. Granulocyte stimulating factor attenuates hypoxic-ischemic brain injury by inhibiting apoptosis in neonatal rats. Yonsei Med J 2008;49:836\u2013842.","journal-title":"Yonsei Med J"},{"key":"BFpr2017243_CR92","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/jcbfm.1995.76","volume":"15","author":"PB Kirschner","year":"1995","unstructured":"Kirschner PB, Henshaw R, Weise J et al. Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats. J Cereb Blood Flow Metab 1995;15:619\u2013623.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFpr2017243_CR93","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000105471","volume":"29","author":"TL Wood","year":"2007","unstructured":"Wood TL, Loladze V, Altieri S et al. Delayed IGF-1 administration rescues oligodendrocyte progenitors from glutamate-induced cell death and hypoxic-ischemic brain damage. Dev Neurosci 2007;29:302\u2013310.","journal-title":"Dev Neurosci"},{"key":"BFpr2017243_CR94","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.expneurol.2009.03.021","volume":"217","author":"S Lin","year":"2009","unstructured":"Lin S, Fan L, Rhodes PG, Cai Z . Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats. Exp Neurol 2009;217:361\u2013370.","journal-title":"Exp Neurol"},{"key":"BFpr2017243_CR95","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/WNL.0000000000000278","volume":"82","author":"Q Vu","year":"2014","unstructured":"Vu Q, Xie K, Eckert M, Zhao W, Cramer SC . Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke. Neurology 2014;82:1277\u20131286.","journal-title":"Neurology"},{"key":"BFpr2017243_CR96","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jpeds.2013.10.084","volume":"164","author":"MJ Benders","year":"2014","unstructured":"Benders MJ, van der Aa NE, Roks M et al. Feasibility and safety of erythropoietin for neuroprotection after perinatal arterial ischemic stroke. J Pediatr 2014;164:481\u20136.e1-2.","journal-title":"J Pediatr"},{"key":"BFpr2017243_CR97","doi-asserted-by":"publisher","first-page":"e1135","DOI":"10.1542\/peds.2009-2268","volume":"125","author":"H Elmahdy","year":"2010","unstructured":"Elmahdy H, El-Mashad A-R, El-Bahrawy H, El-Gohary T, El-Barbary A, Aly H . Human recombinant erythropoietin in asphyxia neonatorum: pilot trial. Pediatrics 2010;125:e1135\u2013e1142.","journal-title":"Pediatrics"},{"key":"BFpr2017243_CR98","doi-asserted-by":"crossref","unstructured":"Baserga MC, Beachy JC, Roberts JK et al. Darbepoetin Administration to Neonates Undergoing Cooling for Encephalopathy (DANCE): a safety and pharmacokinetic trial. Pediatr Res 2015: 3\u201310.","DOI":"10.1038\/pr.2015.101"},{"key":"BFpr2017243_CR99","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1542\/peds.2012-0498","volume":"130","author":"YW Wu","year":"2012","unstructured":"Wu YW, Bauer LA, Ballard RA et al. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics 2012;130:683\u2013691.","journal-title":"Pediatrics"},{"key":"BFpr2017243_CR100","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.pediatrneurol.2014.08.010","volume":"51","author":"EE Rogers","year":"2014","unstructured":"Rogers EE, Bonifacio SL, Glass HC et al. Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy. Pediatr Neurol 2014;51:657\u2013662.","journal-title":"Pediatr Neurol"},{"key":"BFpr2017243_CR101","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1542\/peds.2008-3553","volume":"124","author":"C Zhu","year":"2009","unstructured":"Zhu C, Kang W, Xu F et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009;124:e218\u2013e226.","journal-title":"Pediatrics"},{"key":"BFpr2017243_CR102","unstructured":"Wu YW, Mathur AM, Chang T et al. High-dose erythropoietin and hypothermia for hypoxic-ischemic encephalopathy: a phase II trial. Pediatrics 2016;137 doi:https:\/\/doi.org\/10.152\/peds.2016-0191."},{"key":"BFpr2017243_CR103","doi-asserted-by":"crossref","unstructured":"Mulkey SB, Ramakrishnaiah RH, McKinstry RC et al. Erythropoietin and brain magnetic resonance imaging findings in hypoxic-ischemic encephalopathy: volume of acute brain injury and 1-year neurodevelopmental outcome. J Pediatr 2017: 3\u20136.","DOI":"10.1016\/j.jpeds.2017.03.053"},{"key":"BFpr2017243_CR104","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3109\/14767058.2011.648236","volume":"25","author":"MS El Shimi","year":"2012","unstructured":"El Shimi MS, Hassanein SMA, Mohamed MH et al. Predictive value of vascular endothelial growth factor in preterm neonates with intraventricular haemorrhage. J Matern Fetal Neonatal Med 2012;25:1586\u20131590.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"BFpr2017243_CR105","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00381-002-0567-2","volume":"18","author":"P Koehne","year":"2002","unstructured":"Koehne P, Hochhaus F, Felderhoff-Mueser U, Ring-Mrozik E, Obladen M, B\u00fchrer C . Vascular endothelial growth factor and erythropoietin concentrations in cerebrospinal fluid of children with hydrocephalus. Childs Nerv Syst 2002;18:137\u2013141.","journal-title":"Childs Nerv Syst"},{"key":"BFpr2017243_CR106","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3923\/pjbs.2009.1468.1473","volume":"12","author":"SS Imam","year":"2009","unstructured":"Imam SS, Gad GI, Atef SH, Shawky MA . Cord blood brain derived neurotrophic factor: diagnostic and prognostic marker in fullterm newborns with perinatal asphyxia. Pak J Biol Sci 2009;12:1498\u20131504.","journal-title":"Pak J Biol Sci"},{"key":"BFpr2017243_CR107","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.braindev.2008.09.004","volume":"31","author":"H Aly","year":"2009","unstructured":"Aly H, Hassanein S, Nada A, Mohamed MH, Atef SH, Atiea W . Vascular endothelial growth factor in neonates with perinatal asphyxia. Brain Dev 2009;31:600\u2013604.","journal-title":"Brain Dev"},{"key":"BFpr2017243_CR108","doi-asserted-by":"crossref","unstructured":"Chalak LF, S\u00e1nchez PJ, Adams-Huet B, Laptook AR, Heyne RJ, Rosenfeld CR . Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy. J Pediatr 2014: 164.","DOI":"10.1016\/j.jpeds.2013.10.067"},{"issue":"3","key":"BFpr2017243_CR109","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000448702","volume":"111","author":"Deirdre U. Sweetman","year":"2016","unstructured":"Sweetman DU, Onwuneme C, Watson WR, Murphy JFA, Molloy EJ . Perinatal asphyxia and erythropoietin and VEGF: serial serum and cerebrospinal fluid responses. Neonatology 2017: 253\u2013259.","journal-title":"Neonatology"},{"key":"BFpr2017243_CR110","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1161\/STROKEAHA.115.012383","volume":"47","author":"TM Stanne","year":"2016","unstructured":"Stanne TM, Aberg ND, Nilsson S et al. Low circulating acute brain-derived neurotrophic factor levels are associated with poor long-term functional outcome after ischemic stroke. Stroke 2016;47:1943\u20131945.","journal-title":"Stroke"},{"key":"BFpr2017243_CR111","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.08.026","volume":"24","author":"Y Chen","year":"2015","unstructured":"Chen Y, Lu B, Wang J et al. Circulating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: predictive role in ischemic stroke patients. J Stroke Cerebrovasc Dis 2015;24:319\u2013326.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"BFpr2017243_CR112","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","volume":"164","author":"YS Chang","year":"2014","unstructured":"Chang YS, Ahn SY, Yoo HS et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr 2014;164:966\u201372.e6.","journal-title":"J Pediatr"},{"key":"BFpr2017243_CR113","doi-asserted-by":"publisher","first-page":"973.e1","DOI":"10.1016\/j.jpeds.2013.11.036","volume":"164","author":"CM Cotten","year":"2014","unstructured":"Cotten CM, Murtha AP, Goldberg RN et al. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J Pediatr 2014;164:973.e1\u2013979.e1.","journal-title":"J Pediatr"},{"key":"BFpr2017243_CR114","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.pediatrneurol.2012.10.010","volume":"48","author":"T Verina","year":"2013","unstructured":"Verina T, Fatemi A, Johnston MV, Comi AM . Pluripotent possibilities: human umbilical cord blood cell treatment after neonatal brain injury. Pediatr Neurol 2013;48:346\u2013354.","journal-title":"Pediatr Neurol"},{"key":"BFpr2017243_CR115","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS ONE 2012;7:e47559.","journal-title":"PLoS ONE"},{"key":"BFpr2017243_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-014-0721-8","volume":"19","author":"T-H Tsai","year":"2015","unstructured":"Tsai T-H, Lu C-H, Wallace CG et al. Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. Crit Care 2015;19:1\u20139.","journal-title":"Crit Care"},{"key":"BFpr2017243_CR117","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF03402029","volume":"8","author":"H Ehrenreich","year":"2002","unstructured":"Ehrenreich H, Hasselblatt M, Dembowski C et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002;8:495\u2013505.","journal-title":"Mol Med"},{"key":"BFpr2017243_CR118","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","volume":"40","author":"H Ehrenreich","year":"2009","unstructured":"Ehrenreich H, Weissenborn K, Prange H et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 2009;40:e647\u2013e656.","journal-title":"Stroke"},{"key":"BFpr2017243_CR119","doi-asserted-by":"crossref","unstructured":"Boncoraglio GB, Bersano A, Candelise L, Reynolds BA, Parati EA . Stem cell transplantation for ischemic stroke. Cochrane Database Syst Rev 2010: CD007231.","DOI":"10.1002\/14651858.CD007231.pub2"},{"key":"BFpr2017243_CR120","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3171\/jns.2005.103.1.0038","volume":"103","author":"D Kondziolka","year":"2005","unstructured":"Kondziolka D, Steinberg GK, Wechsler L et al. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 2005;103:38\u201345.","journal-title":"J Neurosurg"},{"key":"BFpr2017243_CR121","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","volume":"16","author":"DC Hess","year":"2017","unstructured":"Hess DC, Wechsler LR, Clark WM et al. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 2017;16:360\u2013368.","journal-title":"Lancet Neurol"},{"key":"BFpr2017243_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2010.06.013","volume":"1353","author":"G-W Cho","year":"2010","unstructured":"Cho G-W, Koh S-H, Kim M-H et al. The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke. Brain Res 2010;1353:1\u201313.","journal-title":"Brain Res"},{"key":"BFpr2017243_CR123","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fnint.2011.00089","volume":"5","author":"Y Wang","year":"2011","unstructured":"Wang Y, Geng T, Ni A, Yin H, Han B . Effects of transplanted GDNF gene modified marrow stromal cells on focal cerebral ischemia in rats. Front Integr Neurosci 2011;5:89.","journal-title":"Front Integr Neurosci"},{"key":"BFpr2017243_CR124","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4103\/1673-5374.191220","volume":"11","author":"Y Yao","year":"2016","unstructured":"Yao Y, Zheng X, Zhang S et al. Transplantation of vascular endothelial growth factor-modified neural stem\/progenitor cells promotes the recovery of neurological function following hypoxic-ischemic brain damage. Neural Regen Res 2016;11:1456\u20131463.","journal-title":"Neural Regen Res"},{"key":"BFpr2017243_CR125","first-page":"544","volume":"46","author":"H Wang","year":"2008","unstructured":"Wang H, Zhu X, Wang L et al. [Brain-derived neurotrophic factor and neural stem cells transplantation in treatment of hypoxic-ischemic brain injury in rats]. Zhonghua Er Ke Za Zhi 2008;46:544\u2013549.","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"BFpr2017243_CR126","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3727\/096368916X692861","volume":"26","author":"SY Ahn","year":"2016","unstructured":"Ahn SY, Chang YS, Sung DK, Sung SI, Ahn J-Y, Park WS . Pivotal role of brain derived neurotrophic factor secreted by mesenchymal stem cells in severe intraventricular hemorrhage in the newborn rats. Cell Transplant 2016;26:145\u2013156.","journal-title":"Cell Transplant"},{"key":"BFpr2017243_CR127","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/jnr.20704","volume":"83","author":"AP Bemelmans","year":"2006","unstructured":"Bemelmans AP, Husson I, Jaquet M, Mallet J, Kosofsky BE, Gressens P . Lentiviral-mediated gene transfer of brain-derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge. J Neurosci Res 2006;83:50\u201360.","journal-title":"J Neurosci Res"},{"key":"BFpr2017243_CR128","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.neuroscience.2006.02.057","volume":"139","author":"TC Wen","year":"2006","unstructured":"Wen TC, Rogido M, Peng H, Genetta T, Moore J, Sola A . Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats. Neuroscience 2006;139:803\u2013811.","journal-title":"Neuroscience"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2017243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2017243","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/pr.2017.243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/pr2017243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:03:35Z","timestamp":1684616615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2017243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":128,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFpr2017243"],"URL":"https:\/\/doi.org\/10.1038\/pr.2017.243","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]},"assertion":[{"value":"23 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was supported by the Netherlands Organisation for Health Research and Development (ZonMW), the Netherlands (TAS Research Grant 11600200). The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}